RT-PCR or reverse transcription PCR refers to PCR that uses product of an RT reaction as template. In effect, the PCR amplifies cDNA fragments. In one-tube RT-PCR, RNA and PCR primers are added to a reaction mix that is thermocycled for RT first followed by for PCR. One-tube RT-PCR reaction mixes are supplied by many manufacturers. Drawbacks to their use include lack of flexibility. Otherwise, RT-PCR is a two step process.
Step I - RT
See Reverse transcription for more on RT
Specificity of RT-PCR can be improved by using gene specific primers for RT.
It is good to include a negative control reaction in the experiment. This is set up like the test reaction, except that RT enzyme is not added to it. Absence of PCR products when using the control reaction as template indicates that the PCR products did not arise from genomic DNA contamination of the RNA sample. If the PCR primers are across introns, then this control is not needed as PCR products arising from any genomic DNA contamination will be of larger size or may even not be obtained (if the introns are large).
Step II - PCR
A fraction, usually 5-20%, of the RT products is directly used in PCR using gene-specific primers.
Notes
Genomic DNA contamination may be irrelavant if it gives rise to PCR products of sizes different than those arising from cDNA. Otherwise, e.g., when primers are designed from same genomic exon, one needs to treat the RNA preparation with DNAse (RNAse-free).
The process of enrichment of mRNA (poly-A+) from total RNA using oligo-dT-affinity also reduces DNA contamination.
One can also add to the RNA sample a combination of restriction enzymes to specifically cleave genomic DNA. Ashkenas et al. (Biotechniques 39:1 2005) suggest making a cocktail of AluI, NlaIII, Sau96I and StyD4I - all frequent cutters - andd adding it to the RT reaction at 1 U ea. enzyme / 20 ul RT reaction. Before RT, the reaction mixture is incubated at 37 deg for 30 min. Then, after RT, the reaction is treated at 94 deg for 10 min to kill the restriction enzymes.
StandardBioTools2月公布2024年第四季度及全年財務業績,2024年收入1.751億美元,較2023年1.92億下降9%;凈虧損1.687億美元,較2023年凈虧損1.643億增加2.......
質譜流式系統、組織質譜成像系統采購項目中標結果公告發布時間:2024-03-0510:41一、項目編號:1069-244Z20240341(招標文件編號:招案2024-0341)二、項目名稱:質譜流式......
近日,StandardBioTools公布2023年第四季度及全年財務業績,2023年收入1.06億美元,較2022年9794.8萬增長8.6%;凈虧損......
近日,StandardBioTools (原“Fluidigm富魯達”)發布2022財年財報,全年GAAP營收為9790萬美元,核心產品和服務營收為9450萬美元。第四季度及全年財政概況20......
StandardBioTools近日表示,其董事會已授權在公開市場或協商交易中回購至多2000萬美元的普通股,直至2023年12月31日。這家生命科學研究工具提供商表示,預計將以手頭現金進行回購,并認......
StandardBioTools近日收盤后報告稱,由于該公司繼續實施今年早些時候啟動的新企業戰略,其第二季度收入同比暴跌39%,凈虧損增加了兩倍多。1月份,這家前身為Fluidigm的公司宣布將更名并......
根據新型冠狀病毒感染的肺炎實驗室檢測技術指南(第二版),新型冠狀病毒感染的肺炎實驗室檢測主要是實時熒光RT-PCR方法。新型冠狀病毒核酸測定(實時熒光RT-PCR方法)1.推薦選用針對新型冠狀病毒的O......
2010年1月6日,北京–安捷倫科技公司(NYSE:A)今天宣布推出了AffinityScript一步法RT-PCR試劑盒。這一試劑盒的問世意味著安捷倫Stratagene產品部又一次攜市場領先的高性......
本文主要談談個人對RT-PCR的一些看法,以及操作過程中的注意點。......